Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Flamand

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 24, 2018
[Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision]A Martin-Malburet, G Marcq, X Leroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1991
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisoloneM L Alegre, P Vandenabeele, M Depierreux, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Dendritic cells can be used as physiological adjuvant in vivoM Moser, T Sornasse, T De Smedt, et al.
The Journal of Clinical Investigation|June 22, 1999
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejectionA Le Moine, V Flamand, F X Demoor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
CD40 ligation prevents neonatal induction of transplantation toleranceV Flamand, V Donckier, F X Demoor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in miceA Le Moine, M Surquin, F X Demoor, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]J Bernhard, J Patard, P Bigot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 15, 2018
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCRB Reix, J-C Bernhard, J-J Patard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†A Kramar, S Negrier, R Sylvester, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 24, 2018
[Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision]A Martin-Malburet, G Marcq, X Leroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1991
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisoloneM L Alegre, P Vandenabeele, M Depierreux, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Dendritic cells can be used as physiological adjuvant in vivoM Moser, T Sornasse, T De Smedt, et al.
The Journal of Clinical Investigation|June 22, 1999
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejectionA Le Moine, V Flamand, F X Demoor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
CD40 ligation prevents neonatal induction of transplantation toleranceV Flamand, V Donckier, F X Demoor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in miceA Le Moine, M Surquin, F X Demoor, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]J Bernhard, J Patard, P Bigot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 15, 2018
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCRB Reix, J-C Bernhard, J-J Patard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†A Kramar, S Negrier, R Sylvester, et al.
Pageof 5